PLUR.TA
Price:
$1018
Market Cap:
$22.02M
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the muscle recovery following surgery for hip fracture; and Phase I/II clinical trial for the treatment of steroid-refractory graft versus host disease in collaboration with Tel Aviv Sourasky Medical Center, as well as completed a Phase II clinical trial for the treatment of acute respiratory distress syndrome associated with COVID-19 and a Phase I clinical trial for inc...[Read more]
Industry
Biotechnology
IPO Date
2011-10-25
Stock Exchange
TLV
Ticker
PLUR.TA
According to Pluri Inc.’s latest financial reports and current stock price. The company's current ROE is 468.40%. This represents a change of -132.97% compared to the average of -1420.54% of the last 4 quarters.
The mean historical ROE of Pluri Inc. over the last ten years is -2231.34%. The current 468.40% ROE has changed -120.99% with respect to the historical average. Over the past ten years (40 quarters), PLUR.TA's ROE was at its highest in in the March 2024 quarter at 1.49%. The ROE was at its lowest in in the June 2024 quarter at -5967.71%.
Average
-2231.34%
Median
-91.80%
Minimum
-21758.33%
Maximum
339.81%
Discovering the peaks and valleys of Pluri Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.16%
Maximum Annual ROE = 339.81%
Minimum Annual Increase = -101.56%
Minimum Annual ROE = -21758.33%
| Year | ROE | Change |
|---|---|---|
| 2025 | 339.81% | -101.56% |
| 2024 | -21758.33% | 10.16% |
| 2023 | -212.06% | 54.46% |
| 2022 | -137.29% | 57.36% |
| 2021 | -87.25% | 67.91% |
| 2020 | -51.96% | -67.88% |
| 2019 | -161.80% | 76.55% |
| 2018 | -91.65% | -0.32% |
| 2017 | -91.94% | 50.92% |
| 2016 | -60.92% | 43.55% |
The current ROE of Pluri Inc. (PLUR.TA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7210.19%
5-year avg
-4371.03%
10-year avg
-2231.34%
Pluri Inc.’s ROE is greater than Kadimastem Ltd (0.16%), greater than Enlivex Therapeutics Ltd. (-62.91%), greater than BioLineRx Ltd. (-49.74%), greater than Can-Fite BioPharma Ltd. (-182.93%), greater than Nissan Medical Industries Ltd (0.00%), greater than Clal Biotechnology Industries Ltd. (-104.31%), greater than Matricelf Ltd (-273.32%), greater than G.F.C Green Fields Capital Ltd. (0.01%), less than Seach Medical Group Ltd (16.71%), less than Evogene Ltd. (438.89%),
| Company | ROE | Market cap |
|---|---|---|
| 0.16% | $125.73M | |
| -62.91% | $74.32M | |
| -49.74% | $42.86M | |
| -182.93% | $51.22M | |
| 0.00% | $82.48M | |
| -104.31% | $50.82M | |
| -273.32% | $95.28M | |
| 0.01% | $131.62M | |
| 16.71% | $96.49M | |
| 438.89% | $30.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluri Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pluri Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pluri Inc.'s ROE?
How is the ROE calculated for Pluri Inc. (PLUR.TA)?
What is the highest ROE for Pluri Inc. (PLUR.TA)?
What is the 3-year average ROE for Pluri Inc. (PLUR.TA)?
What is the 5-year average ROE for Pluri Inc. (PLUR.TA)?
How does the current ROE for Pluri Inc. (PLUR.TA) compare to its historical average?